Psoriasis News and Research

Latest Psoriasis News and Research

Sun avoidance may be almost as hazardous to health as cigarette smoking

Available on Amazon, Embrace the Sun, by authors Marc B. Sorenson, Ed.D.and William B. Grant, Ph.D.,claim that sun avoidance may be nearly as hazardous to your health as cigarette smoking!

3 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Survey: Psoriasis patients may face a long journey to achieve goal of clear skin

Novartis announced today the publication of global Clear about Psoriasis survey data in the Journal of the European Academy of Dermatology and Venereology. The publication highlights that despite clear or almost clear skin being more achievable than ever before, patients may face a long journey to attain this reality.

From Novartis 29 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Skin tone makes big difference in diagnosis and treatment of dermatologic conditions

Should a health care provider consider the color of a patient's skin in making a medical decision?

18 Jun 2018

Researchers uncover racial differences in debilitating itchy skin condition

An international team led by Johns Hopkins Medicine researchers has conducted what is believed to be the largest detailed published study of people with a poorly understood skin condition known as prurigo nodularis.

14 Jun 2018

Price check on drug ads: Would revealing costs help patients control spending?

President Donald Trump wants to control spending on drugs. One of his big ideas: include prices in advertisements, just like warnings about side effects.

6 Jun 2018

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

The American Autoimmune Related Diseases Association is proud and honored to announce its collaborative partnership with Allegheny Health Network and its new Autoimmunity Institute.

25 May 2018

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

The hotter our body temperature, the more our bodies speed up a key defense system that fights against tumors, wounds or infections, new research by a multidisciplinary team of mathematicians and biologists from the Universities of Warwick and Manchester has found.

21 May 2018

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

President Donald Trump didn't mention Novartis or other drugmakers by name last year when he said the industry is "getting away with murder."

11 May 2018

New study launched to examine effects of rheumatologic agent on bone health

Researchers at Hospital for Special Surgery have launched a pilot study to see how a drug that treats several related autoimmune disorders affects the skeleton.

7 May 2018

UTSW study provides insight into potential new therapeutic approaches for skin diseases

Research at UT Southwestern has shown that targeting metabolism in growing cells holds promise for the treatment of skin diseases like psoriasis that are characterized by skin overgrowth resulting from excess cell division, known as hyperproliferation.

4 May 2018

Common therapy options for psoriasis can help reduce coronary plaque, study shows

Late-breaking clinical science shows common therapy options for psoriasis (PSO)-a chronic inflammatory skin disease-can help reduce coronary plaque. The authors found that not only do the treatments reduce the volume of the plaque, but also the plaque becomes less inflammatory over time harboring fewer characteristics prone to rupture and cause a heart attack.

26 Apr 2018

Researchers gain ground-breaking insights into how inflammatory diseases work

A research team from Queen's University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.

25 Apr 2018

Compound derived from immune cells treats psoriasis in mice

A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis.

18 Apr 2018

New treatment shows promise to fight against serious inflammatory disease

Still's disease is a serious orphan disease manifested by high fevers, skin and joint involvement, including paralysis, as well as damage to other organs such as the liver or spleen. It is caused by a deregulation of the immune system triggering an acute inflammatory response.

27 Feb 2018

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.

From J&J Innovative Medicine 22 Feb 2018

Penn study sheds new light on immune cell identity

Almost all cells in the human body have identical DNA sequences, yet there are 200-plus cell types with different sizes, shapes, and chemical compositions. Determining what parts of the genome are read to make protein and which are silenced is orchestrated by proteins called transcription factors.

21 Feb 2018

Psoriasis News and Research

Latest Psoriasis News and Research

Sun avoidance may be almost as hazardous to health as cigarette smoking

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Survey: Psoriasis patients may face a long journey to achieve goal of clear skin

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Skin tone makes big difference in diagnosis and treatment of dermatologic conditions

Researchers uncover racial differences in debilitating itchy skin condition

Price check on drug ads: Would revealing costs help patients control spending?

AARDA collaborates with Allegheny Health Network and new AHN Autoimmunity Institute

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

Study: Psoriasis patients taking Humira show no change in aortic inflammation

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

New study launched to examine effects of rheumatologic agent on bone health

UTSW study provides insight into potential new therapeutic approaches for skin diseases

Common therapy options for psoriasis can help reduce coronary plaque, study shows

Researchers gain ground-breaking insights into how inflammatory diseases work

Compound derived from immune cells treats psoriasis in mice

New treatment shows promise to fight against serious inflammatory disease

New data from VOYAGE 2 trial shows promising results for Janssen’s guselkumab treatment

Penn study sheds new light on immune cell identity

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Psoriasis News and Research

Latest Psoriasis News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in